“Chemo-Enzymatic Transformation of Sugars into Nucleosides of Biological Importance”
ISTC Grant № B-1640. 2008-2010.

“Creation of promising antiangiogenic peptide drugs and investigation of their biological activity using a model of neovascular diseases of the organ of sight”
RFBR grant № 08-04-13626-ofi_c. 2008-2009.

“Enzyme synthesis of nucleosides with native and modified heterobases and/or sugars”
RFBR grant № 08-04-9057-bel-a. 2008-2009.

“Development of methods of preparation, preparation and purification of proteins. Delivering of proteins to IBMC RAMS, IC RAS, IFCM Checking and testing of inhibitors for inhibition of enzyme activity (SE “Kristallizator”)”
Russian Federal Space Programm to 2006-2015 years. Goskontrakt № 851-5383/07 from 31.05.2007. 2007-2009.

“Investigation of structural bases of functioning of phosphopantetheine adenylyltransferase from Mycobacterium tuberculosis”
RFBR grant № 07-04-00371-a. 2007-2009.

“Development of biotechnology of modified polypeptide drugs on the basis of self-cleaving hybrid proteins”
RFBR grant № 06-04-08375-ofi. 2006-2007.

“Genetic-engineering technologies for preparation of recombinant polypeptides for medical use”
Federal Target Programme "Research and Development in Priority Fields of Science and technology for 2002-2006" Goskontrakt № 02.435.11.3014 from 01.06.2005. FASI. Parent organization – PushSU. 2005-2006.

“Development of technologies of transglycosylation with the use of recombinant phosphorylase systems for the synthesis of new-generation drugs on the basis of purine bases”
FTP “National Technological Base for 2002 - 2006”. Goskontrakt № 35.663.11.0089 from 15.05.2002. RF Federal agency for industry (RosProm).2002-2006.

“Creation of substances of modern antiviral drugs on the basis of fundamentally new modified nucleosides with the use of systems of genetically engineered enzymes”
RFBR grant № 05-04-08013-ofi_p. 2005 – 2006.

“Prospects of the use of hybrid proteins capable of autocatalytic cleavage for the preparation of recombinant polypeptides in biotechnological process”
RFBR grant №. 04-04-0800 -ofi_a. 2004-2005.

“The use of genetically engineered nucleosidephosphorylases in modern biotechnologies for drug preparation”
RFBR grant № 04-04-08115-ofi_a. 2004-2005.

“Drugs on the basis of modified nucleosides for the therapy of leucosis and autoimmune diseases”
FTP “Research and Development in Priority Fields of Science and Technology”. Goskontrakt № 43.073.11.2516 from 21.05.2002. RF Ministry of Science and Technology. 2002-2004.

“Recombinant polypeptides of inhibiting action on pathogenic bacteria, viruses and tumor cells”
RFBR grant № 02-04-48097. 2002-2004.